Department of Public Health, Purdue University, West Lafayette, Indiana, USA.
Cancer Prevention and Control Program, Indiana University Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.
J Womens Health (Larchmt). 2021 Oct;30(10):1476-1484. doi: 10.1089/jwh.2020.8727. Epub 2021 Jan 11.
Many women see an obstetrician/gynecologist (OB/GYN) annually and receive their primary care from an OB/GYN. Understanding OB/GYNs' human papillomavirus (HPV) vaccination practices, including knowledge of and barriers to vaccination, is essential to design effective interventions to increase vaccination. This study evaluated OB/GYN knowledge, attitudes, and beliefs regarding vaccinating both younger (18-26 years) and mid-adult (27-45 years) women. Data were collected from OB/GYN providers in October 2019 through a nationwide web-based survey. Items included the following: HPV-related vaccination practices, recommendation strength, knowledge (seven items), benefits (four items), and barriers (eight items). The sample ( = 224) was majority were White (69%), men (56%), and practice in suburban clinics (55%). Most (84%) reported they usually or always recommend HPV vaccine to eligible patients, but estimated only about half (51%) of other OB/GYNs did the same. Recommendation strength varied by patient age with 84% strongly recommending it to patients ≤18 years, compared with 79% and 25% strongly recommending to younger and mid-adult patients, respectively ( < 0.01). Participants reported lower benefits ( = 0.007) and higher barriers ( < 0.001) for 27- to 45-year-old patients compared with younger patients. Cost was the most frequently reported barrier, regardless of patient age. Overall knowledge was high ( = 5.2/7) but 33% of participants did not know the vaccine was safe while breastfeeding. Although providers reported strongly and consistently recommending the HPV vaccination to their adult patients, there were gaps in knowledge and attitudinal barriers that need to be addressed. Provider performance feedback may be important in improving HPV vaccination awareness among providers.
许多女性每年都会看妇产科医生,并由妇产科医生提供主要的医疗服务。了解妇产科医生的人乳头瘤病毒(HPV)疫苗接种实践,包括对疫苗接种的了解和障碍,对于设计有效的干预措施以增加疫苗接种至关重要。本研究评估了妇产科医生在为年轻(18-26 岁)和中年(27-45 岁)女性接种疫苗方面的知识、态度和信念。数据于 2019 年 10 月通过全国性的网络调查从妇产科医生提供者那里收集。项目包括 HPV 相关疫苗接种实践、推荐强度、知识(7 项)、益处(4 项)和障碍(8 项)。样本( = 224)主要是白人(69%)、男性(56%)和在郊区诊所工作(55%)。大多数(84%)表示他们通常或总是向符合条件的患者推荐 HPV 疫苗,但估计只有约一半(51%)的其他妇产科医生也这样做。推荐强度因患者年龄而异,84%强烈建议为≤18 岁的患者接种疫苗,而分别为 79%和 25%强烈建议为年轻和中年患者接种疫苗( < 0.01)。与年轻患者相比,参与者报告称 27-45 岁患者的益处( = 0.007)较低,障碍( < 0.001)较高。无论患者年龄大小,费用都是最常报告的障碍。总体知识水平较高( = 5.2/7),但 33%的参与者不知道疫苗在母乳喂养期间是安全的。尽管提供者报告强烈并一致地向他们的成年患者推荐 HPV 疫苗接种,但在知识和态度障碍方面仍存在差距,需要加以解决。提供提供者绩效反馈可能对提高提供者对 HPV 疫苗接种的认识很重要。